Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

TXMD

TherapeuticsMD (TXMD)

TherapeuticsMD Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:TXMD
DateHeureSourceTitreSymboleSociété
10/05/202422h18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TXMDTherapeuticsMD Inc
10/05/202422h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TXMDTherapeuticsMD Inc
10/05/202422h05Business WireTherapeuticsMD Announces First Quarter 2024 Financial ResultsNASDAQ:TXMDTherapeuticsMD Inc
29/03/202421h00Business WireTherapeuticsMD Announces Full Year 2023 Financial ResultsNASDAQ:TXMDTherapeuticsMD Inc
07/12/202322h51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXMDTherapeuticsMD Inc
06/12/202317h36Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TXMDTherapeuticsMD Inc
17/11/202315h28Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TXMDTherapeuticsMD Inc
14/11/202322h05Business WireTherapeuticsMD Announces Third Quarter 2023 Financial ResultsNASDAQ:TXMDTherapeuticsMD Inc
21/08/202322h20Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TXMDTherapeuticsMD Inc
14/08/202312h50Business WireTherapeuticsMD Announces Second Quarter 2023 Financial ResultsNASDAQ:TXMDTherapeuticsMD Inc
29/06/202323h22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TXMDTherapeuticsMD Inc
28/06/202313h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TXMDTherapeuticsMD Inc
17/05/202323h05Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:TXMDTherapeuticsMD Inc
17/05/202323h02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:TXMDTherapeuticsMD Inc
15/05/202322h38Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TXMDTherapeuticsMD Inc
15/05/202322h05Business WireTherapeuticsMD Announces First Quarter 2023 Financial ResultsNASDAQ:TXMDTherapeuticsMD Inc
04/05/202322h40Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:TXMDTherapeuticsMD Inc
01/05/202323h03Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:TXMDTherapeuticsMD Inc
07/04/202322h48Edgar (US Regulatory)Annual Report (10-k)NASDAQ:TXMDTherapeuticsMD Inc
07/04/202322h01Business WireTherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model TransitionNASDAQ:TXMDTherapeuticsMD Inc
31/03/202323h04Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:TXMDTherapeuticsMD Inc
13/02/202323h25Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:TXMDTherapeuticsMD Inc
06/01/202323h31Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:TXMDTherapeuticsMD Inc
03/01/202312h50Business WireTherapeuticsMD Completes Transaction to License Its Products to Mayne PharmaNASDAQ:TXMDTherapeuticsMD Inc
05/12/202208h39TipRanksTherapeuticsMD Inks Licensing Deal with Mayne PharmaNASDAQ:TXMDTherapeuticsMD Inc
05/12/202200h00Business WireTherapeuticsMD Announces Definitive Agreements to License its Products to Mayne PharmaNASDAQ:TXMDTherapeuticsMD Inc
14/11/202223h23Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:TXMDTherapeuticsMD Inc
14/11/202222h05Business WireTherapeuticsMD Announces Third Quarter 2022 Financial ResultsNASDAQ:TXMDTherapeuticsMD Inc
31/10/202211h50Business WireTherapeuticsMD Announces Additional $7 Million Private PlacementNASDAQ:TXMDTherapeuticsMD Inc
03/10/202212h50Business WireTherapeuticsMD Announces $7 Million Private PlacementNASDAQ:TXMDTherapeuticsMD Inc
 Showing the most relevant articles for your search:NASDAQ:TXMD

Dernières Valeurs Consultées